Emkay Global Financial's research report on Bandhan Bank
Bandhan Bank saw sharp correction post 2Q results, due to spike in NPAs (mainly from MFI), delay in CGFMU recovery, sub-par industry growth and management saga. But of recent, the stock has seen an upmove (+10%) mainly owing to the recent newsflow around the bank’s plan to sell distressed home loans (of up to Rs7.8bn) to ARC (mainly acquired from Gruh Fin) which should lead to NPA reduction, as & when the sale is concluded. Bank expects CGFMU recovery by end-Dec/early-Jan – once the audit process is complete, while the KMP, incl. the ED/CFO of the marquee bank, should mostly join around the same time. Bank highlights that impact of the recent RBI guidelines on increasing RWA on unsecured loans will be only 25bps on CET-1. With asset quality and mgmt issues set to gradually resolve, we expect Bank to participate in the MFI growth story in 2HFY24.
Outlook
Valuations are reasonable, with P/ABV at 1.5x/1.2x FY25E/FY26E, with bank set to deliver healthy RoA/RoE of 2.4-2.5%/19-20%; retain BUY on favorable risk-reward; TP: Rs290/sh (on 1.7x Sep-25 ABV).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
